Skip to main content
. 2021 Jul 29;12:722537. doi: 10.3389/fphar.2021.722537

FIGURE 2.

FIGURE 2

In survival and non-survival groups, corticosteroid treatment decreased serum IL-18 (A). Changes of IL-18 after corticosteroid treatment (B). Corticosteroid treatment improved PaO2/FiO2 (C). Changes of PaO2/FiO2 after corticosteroid treatment (D). Corticosteroid treatment increased the neutrophil-to-lymphocyte ratio (E). APACHE II score at day 1, day 3, and day 7 (F).